Bismuth subsalicylate (Pepto-Bismol) reduces hydrogen sulfide production by inhibiting sulfate-reducing bacteria
People with NAION typically lose vision in one eye (unilaterally) and do not typically experience pain with the vision loss
Tirzepatide was initially developed to help manage type 2 diabetes, but recent clinical studies, such as the SURMOUNT-1 trial, have shown that it can also help patients achieve significant weight loss
Each session works from within to promote a luminous, even-toned, and firm complexion
More often than not, patients may need to try lower doses of the medication or an alternative class of GLP-1 agonists, as there is a variation in tolerability profile between them, says Criner
Use of melanotan I and II in the general population